Syrleno

Tablet, 5mg
RxActive license

Active substance (INN)

everolimus

Pharmaceutical form

Pharmaceutical formTablet
Strength5mg
PackagingUkupno 30 tableta u blisteru (3x10) u kartonskoj kutiji
ManufacturerAlkaloid AD Skopje, North Macedonia
Therapeutic groupAntineoplastic and immunomodulating agents (L01EG02)
Marketing authorization holderDRUŠTVO "ALKALOID" D.O.O. PODGORICA
Authorization dateJune 28, 2023

Analogs in Montenegro

4

Other medicines with the same active substance

AFINITORRx
Tablet, 5mgNovartis Pharma Stein AG
AFINITORRx
Tablet, 10mgNovartis Pharma Stein AG
SyrlenoRx
Tablet, 2.5mgAlkaloid AD Skopje
SyrlenoRx
Tablet, 10mgAlkaloid AD Skopje
Source: CInMED register